ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

IFRX InflaRx NV

1.33
-0.06 (-4.32%)
After Hours
Last Updated: 16:00:03
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
InflaRx NV IFRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -4.32% 1.33 16:00:03
Open Price Low Price High Price Close Price Prev Close
1.38 1.28 1.429 1.33 1.39
more quote information »

Recent News

Date Time Source Heading
4/24/202407:30GLOBEInflaRx to Participate in Capital One Securities 1st Annual..
3/21/202407:00GLOBEInflaRx Reports Full Year 2023 Results and Announces INF904..
3/19/202407:30GLOBEInflaRx to Announce Development Plans for INF904 and 2023..
2/22/202407:30GLOBEInflaRx Appoints Jan Medina as Head of Investor Relations
1/25/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202407:30GLOBEInflaRx Announces Initiation of its Commitment Program for..
1/04/202416:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/04/202407:00GLOBEInflaRx Announces Positive Topline Results from the Multiple..
11/06/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202307:30GLOBEInflaRx Announces First Patient Dosed in Phase III Trial..
11/01/202308:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202307:30GLOBEInflaRx Reports Third Quarter 2023 Financial Results and..
9/11/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202307:00GLOBEInflaRx Announces Positive Topline Results from the Single..
8/30/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/30/202307:30GLOBEInflaRx’s Marketing Authorization Application (MAA) for..
8/10/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/10/202307:30GLOBEInflaRx Reports Second Quarter 2023 Financial Results &..
7/12/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/12/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
6/30/202316:06EDGAR2Form F-3 - Registration statement by foreign private issuers
6/28/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/28/202307:30GLOBEInflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
6/21/202307:00GLOBEInflaRx Announces Commercial Launch of Gohibic (vilobelimab)..
5/11/202307:30GLOBEInflaRx Reports First Quarter 2023 Financial and Operating..

Your Recent History

Delayed Upgrade Clock